🇺🇸 Seloken ZOK/Toprol-XL in United States

FDA authorised Seloken ZOK/Toprol-XL on 10 January 1992

Marketing authorisation

FDA — authorised 10 January 1992

  • Application: NDA019962
  • Marketing authorisation holder: MELINTA THERAP
  • Local brand name: TOPROL-XL
  • Indication: TABLET, EXTENDED RELEASE — ORAL
  • Status: approved

Read official source →

Other Cardiovascular approved in United States

Frequently asked questions

Is Seloken ZOK/Toprol-XL approved in United States?

Yes. FDA authorised it on 10 January 1992.

Who is the marketing authorisation holder for Seloken ZOK/Toprol-XL in United States?

MELINTA THERAP holds the US marketing authorisation.